Sign in to continue:

Tuesday, March 10th, 2026

Camden National Corp (CAC) 2025 Annual 10-K Report: Financial Statements, Derivatives, and Portfolio Analysis




Camden National Corporation 2025 Annual Report – Key Investor Insights

Camden National Corporation 2025 Annual Report: Detailed Investor Highlights

Key Points from the 2025 10-K Report

  • Company Overview: Camden National Corporation (CIK: 0000750686), headquartered in Camden, ME, operates as a national commercial bank.
  • Filing Date: March 6, 2026, covering the fiscal year ended December 31, 2025.
  • Recent Business Developments: The report includes numerous updates on share repurchase programs, business acquisitions, loan portfolio composition, and fair value measurements.

Potentially Price-Sensitive Information for Shareholders

  • Business Acquisition:

    Camden National completed an acquisition of Northway Financial Inc. (NFIM) on January 2, 2025. This transaction is reflected in multiple financial reporting contexts, highlighting its significance to the company’s balance sheet and future earnings potential. Investors should note that acquisitions of this scale can materially impact loan portfolios, goodwill, and integration costs, possibly influencing future share valuation.

  • Share Repurchase Program:

    The company has an active share repurchase program, with the latest being “Share Repurchase Program Six.” The program was ongoing through 2024 and 2025. Share repurchase programs are often seen as a signal of management’s confidence in the company’s prospects and can provide price support by reducing the number of shares outstanding.

  • Loan Portfolio and Credit Quality:

    The 10-K details significant segmentation of the loan portfolio, including commercial, consumer, residential, and home equity segments. The report breaks down credit quality by internal credit assessment (Pass, Special Mention, Substandard, Doubtful) and tracks performing versus nonperforming loans. Notably, commercial and commercial real estate portfolios are emphasized, indicating a focus on business lending, which could lead to higher returns but also increased exposure to economic cycles.

  • Fair Value Measurements:

    Extensive fair value disclosures are provided, with financial instruments, derivatives, and securities categorized by fair value hierarchy levels (Level 1, 2, and 3). Movements between these levels and changes in valuation methodology can be indicators of market volatility or shifts in asset liquidity.

  • Hedging and Derivative Activities:

    The company utilizes a range of derivatives, including interest rate contracts, forward contracts, and loan swaps. Both cash flow and fair value hedging strategies are documented, affecting both the income statement and accumulated other comprehensive income (AOCI). Such activities can mitigate risks from interest rate fluctuations but may also introduce complexity and potential earnings volatility.

  • Capital and Equity Changes:

    There are ongoing changes to equity through retained earnings, comprehensive income adjustments, and employee share-based compensation plans (including stock options, restricted stock, and performance shares). These changes impact book value per share and shareholder dilution.

  • Regulatory and Compliance Factors:

    As a regulated entity, Camden National is subject to ongoing oversight. The report references various compliance axes, risk concentrations, and the impact of federal programs such as Federal Reserve and Federal Home Loan Bank advances.

Summary for Investors

Camden National Corporation’s 2025 annual report reveals a year of meaningful corporate activity and financial management. The acquisition of Northway Financial Inc., continued share repurchases, and a diversified loan portfolio underscore management’s growth strategy and capital optimization efforts. The company actively manages risk through hedging strategies and maintains robust disclosures around asset quality and fair value.

For shareholders, the acquisition and share buyback program are the most potentially price-moving developments. The integration of Northway Financial could drive future earnings growth, while share repurchases may bolster EPS and support share prices. However, investors should also monitor economic conditions affecting the commercial loan portfolio and the outcome of ongoing risk management strategies.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are encouraged to review the full 10-K filing and consult with their financial advisors before making investment decisions. The information presented is based on available data from Camden National Corporation’s SEC filings and may be subject to change.




View CAMDEN NATIONAL CORP Historical chart here



APEX Tech Acquisition Inc. Files S-1MEF Registration Statement for 10 Million Units Offering (2026)

APEX Tech Acquisition Inc. Files S-1MEF Registration Statement for Additional Securities Offering APEX Tech Acquisition Inc. Announces S-1MEF Filing to Register Additional Ordinary Shares Underlying Rights Key Highlights Filing of S-1MEF Registration Statement: APEX...

Strata Critical Medical Reports Q4 2025 Results: Revenue, Gross Profit, and Financial Highlights

Strata Critical Medical Reports Strong Q4 2025 Results, Raises 2026 Guidance Strata Critical Medical (Nasdaq: SRTA) Delivers Strong Q4 2025 Results and Raises 2026 Outlook Key Highlights from the Report Q4 2025 revenue reached...

Apartment Investment and Management Company (Aimco) Reports Q4 2025 Results and Provides Plan of Sale and Liquidation Updates

Aimco Reports Q4 2025 Results and Liquidation Plan Updates Aimco Reports Q4 2025 Results and Provides Major Update on Liquidation Plan Key Highlights from Apartment Investment and Management Company (Aimco) Q4 2025 Report Date:...

   Ad